Celltech Metadate CD Shows Morning/Afternoon Control Of ADHD, Label Says
Executive Summary
Celltech Metadate CD given once daily demonstrates control of attention deficit hyperactivity disorder early and late in the school day, product labeling notes.
You may also be interested in...
Ritalin LA Will Be Novartis’ Second Marketed Once-Daily Methylphenidate
Novartis' Ritalin LA will be the company's second once-daily methylphenidate formulation on the market
Ritalin LA Will Be Novartis’ Second Marketed Once-Daily Methylphenidate
Novartis' Ritalin LA will be the company's second once-daily methylphenidate formulation on the market
Alza Concerta Climbs To 15% Of ADHD Market With 170,000 Patients
Alza Concerta holds 15% of the attention deficit hyperactive disorder market, Senior VP-Sales & Marketing Dan Swisher told the company's annual analyst meeting in New York City Feb. 27.